Self‐Amplifying Nanotherapeutic Drugs Homing to Tumors in a Manner of Chain Reaction

Conjugating Aptamer and Mitomycin C with Reductant-Responsive Linker Leading to Synergistically Enhanced Anticancer Effect

(2020) Qiuxia Yang et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Molecularly Engineering Triptolide with Aptamers for High Specificity and Cytotoxicity for Triple-Negative Breast Cancer

(2020) Jiaxuan He et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Selectively Potentiating Hypoxia Levels by Combretastatin A4 Nanomedicine: Toward Highly Enhanced Hypoxia-Activated Prodrug Tirapazamine Therapy for Metastatic Tumors

(2019) Shengcai Yang et al.   ADVANCED MATERIALS

cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo

(2019) Xiaolei Gu et al.   JOURNAL OF CONTROLLED RELEASE

Poly(phenylene ethynylene) Conjugated Polyelectrolytes Synthesized via Chain-Growth Polymerization

(2019) Pradeepkumar Jagadesan et al.   MACROMOLECULES

PI3Kgamma Inhibitor Attenuates Immunosuppressive Effect of Poly( l ‐Glutamic Acid)‐Combretastatin A4 Conjugate in Metastatic Breast Cancer

(2019) Hanjiao Qin et al.   Advanced Science

Combretastatin A4 Nanodrug‐Induced MMP9 Amplification Boosts Tumor‐Selective Release of Doxorubicin Prodrug

(2019) Jian Jiang et al.   ADVANCED MATERIALS

Combretastatin A4 Nanoparticles Combined with Hypoxia-Sensitive Imiquimod: A New Paradigm for the Modulation of Host Immunological Responses during Cancer Treatment

(2019) Na Shen et al.   NANO LETTERS

Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumours

(2018) Qin Dai et al.   ACS Nano

Targeted drug delivery to melanoma

(2018) Qi Liu et al.   ADVANCED DRUG DELIVERY REVIEWS

Advanced Materials by Atom Transfer Radical Polymerization

(2018) Krzysztof Matyjaszewski   ADVANCED MATERIALS

Progress and challenges towards targeted delivery of cancer therapeutics

(2018) Daniel Rosenblum et al.   Nature Communications

A designer self-assembled supramolecule amplifies macrophage immune responses against aggressive cancer

(2018) Ashish Kulkarni et al.   Nature Biomedical Engineering

Aptamer-guided nanomedicines for anticancer drug delivery

(2018) Walhan Alshaer et al.   ADVANCED DRUG DELIVERY REVIEWS

Recent Advances in Targeted Tumor Chemotherapy Based on Smart Nanomedicines

(2018) Si-Yong Qin et al.   Small

Smart nanoparticles assembled by endogenous molecules for siRNA delivery and cancer therapy via CD44 and EGFR dual-targeting

(2018) Yaoyao Liang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Cloaking nanoparticles with protein corona shield for targeted drug delivery

(2018) Jun Yong Oh et al.   Nature Communications

Activation of factor XIII is accompanied by a change in oligomerization state

(2017) Boris A. Anokhin et al.   FEBS Journal

Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy

(2017) Song Shen et al.   NANO LETTERS

Designing nanomedicine for immuno-oncology

(2017) Wen Jiang et al.   Nature Biomedical Engineering

Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions

(2015) Heiko Herwald et al.   THROMBOSIS AND HAEMOSTASIS

Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation

(2014) V. D. Myneni et al.   BLOOD

Targeted drug delivery to tumors: Myths, reality and possibility

(2011) You Han Bae et al.   JOURNAL OF CONTROLLED RELEASE

The unique characteristics of tumor vasculature and preclinical evidence for its selective disruption by Tumor-Vascular Disrupting Agents

(2010) Dietmar W. Siemann   CANCER TREATMENT REVIEWS

Delivering nanomedicine to solid tumors

(2010) Rakesh K. Jain et al.   Nature Reviews Clinical Oncology